PHOSPHOLIPID COMPOSITIONS
Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a benef...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MIKNIS, Gregory, F MONFREGOLA, Luca JIRKOVSKY, Pavel KOBR, Lukas STASZAK-JIRKOVSKY, Jakub HUDSON, Colleen MILADA, Zboncakova DUEX, Jason KANDASAMY, Pitchaimani |
| description | Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a beneficial effect on the inhibition of cancerous cell growth. Methods of administering these compositions are also described.
L'invention concerne des compositions comprenant un extrait de jaune d'oeuf modifié destiné à être utilisé en tant qu'agent anticancéreux efficace. L'extrait de jaune d'oeuf modifié comprend des fractions spécifiques de phosphatidylcholines et de sphingomyélines modifiées et produites à partir d'une synthèse chimique appliquée à l'extrait qui produisent un effet bénéfique sur l'inhibition de la croissance des cellules cancéreuses. L'invention concerne également des méthodes d'administration de ces compositions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2018005735A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2018005735A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2018005735A93</originalsourceid><addsrcrecordid>eNrjZJAM8PAPBmIfzwBPFwVnf98A_2DPEE9_v2AeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIf7m9kYGhhYGBqbmzqaGlMnCoAvFUhWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHOSPHOLIPID COMPOSITIONS</title><source>esp@cenet</source><creator>MIKNIS, Gregory, F ; MONFREGOLA, Luca ; JIRKOVSKY, Pavel ; KOBR, Lukas ; STASZAK-JIRKOVSKY, Jakub ; HUDSON, Colleen ; MILADA, Zboncakova ; DUEX, Jason ; KANDASAMY, Pitchaimani</creator><creatorcontrib>MIKNIS, Gregory, F ; MONFREGOLA, Luca ; JIRKOVSKY, Pavel ; KOBR, Lukas ; STASZAK-JIRKOVSKY, Jakub ; HUDSON, Colleen ; MILADA, Zboncakova ; DUEX, Jason ; KANDASAMY, Pitchaimani</creatorcontrib><description>Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a beneficial effect on the inhibition of cancerous cell growth. Methods of administering these compositions are also described.
L'invention concerne des compositions comprenant un extrait de jaune d'oeuf modifié destiné à être utilisé en tant qu'agent anticancéreux efficace. L'extrait de jaune d'oeuf modifié comprend des fractions spécifiques de phosphatidylcholines et de sphingomyélines modifiées et produites à partir d'une synthèse chimique appliquée à l'extrait qui produisent un effet bénéfique sur l'inhibition de la croissance des cellules cancéreuses. L'invention concerne également des méthodes d'administration de ces compositions.</description><language>eng ; fre</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180201&DB=EPODOC&CC=WO&NR=2018005735A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180201&DB=EPODOC&CC=WO&NR=2018005735A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MIKNIS, Gregory, F</creatorcontrib><creatorcontrib>MONFREGOLA, Luca</creatorcontrib><creatorcontrib>JIRKOVSKY, Pavel</creatorcontrib><creatorcontrib>KOBR, Lukas</creatorcontrib><creatorcontrib>STASZAK-JIRKOVSKY, Jakub</creatorcontrib><creatorcontrib>HUDSON, Colleen</creatorcontrib><creatorcontrib>MILADA, Zboncakova</creatorcontrib><creatorcontrib>DUEX, Jason</creatorcontrib><creatorcontrib>KANDASAMY, Pitchaimani</creatorcontrib><title>PHOSPHOLIPID COMPOSITIONS</title><description>Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a beneficial effect on the inhibition of cancerous cell growth. Methods of administering these compositions are also described.
L'invention concerne des compositions comprenant un extrait de jaune d'oeuf modifié destiné à être utilisé en tant qu'agent anticancéreux efficace. L'extrait de jaune d'oeuf modifié comprend des fractions spécifiques de phosphatidylcholines et de sphingomyélines modifiées et produites à partir d'une synthèse chimique appliquée à l'extrait qui produisent un effet bénéfique sur l'inhibition de la croissance des cellules cancéreuses. L'invention concerne également des méthodes d'administration de ces compositions.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAM8PAPBmIfzwBPFwVnf98A_2DPEE9_v2AeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIf7m9kYGhhYGBqbmzqaGlMnCoAvFUhWA</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>MIKNIS, Gregory, F</creator><creator>MONFREGOLA, Luca</creator><creator>JIRKOVSKY, Pavel</creator><creator>KOBR, Lukas</creator><creator>STASZAK-JIRKOVSKY, Jakub</creator><creator>HUDSON, Colleen</creator><creator>MILADA, Zboncakova</creator><creator>DUEX, Jason</creator><creator>KANDASAMY, Pitchaimani</creator><scope>EVB</scope></search><sort><creationdate>20180201</creationdate><title>PHOSPHOLIPID COMPOSITIONS</title><author>MIKNIS, Gregory, F ; MONFREGOLA, Luca ; JIRKOVSKY, Pavel ; KOBR, Lukas ; STASZAK-JIRKOVSKY, Jakub ; HUDSON, Colleen ; MILADA, Zboncakova ; DUEX, Jason ; KANDASAMY, Pitchaimani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2018005735A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MIKNIS, Gregory, F</creatorcontrib><creatorcontrib>MONFREGOLA, Luca</creatorcontrib><creatorcontrib>JIRKOVSKY, Pavel</creatorcontrib><creatorcontrib>KOBR, Lukas</creatorcontrib><creatorcontrib>STASZAK-JIRKOVSKY, Jakub</creatorcontrib><creatorcontrib>HUDSON, Colleen</creatorcontrib><creatorcontrib>MILADA, Zboncakova</creatorcontrib><creatorcontrib>DUEX, Jason</creatorcontrib><creatorcontrib>KANDASAMY, Pitchaimani</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MIKNIS, Gregory, F</au><au>MONFREGOLA, Luca</au><au>JIRKOVSKY, Pavel</au><au>KOBR, Lukas</au><au>STASZAK-JIRKOVSKY, Jakub</au><au>HUDSON, Colleen</au><au>MILADA, Zboncakova</au><au>DUEX, Jason</au><au>KANDASAMY, Pitchaimani</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHOSPHOLIPID COMPOSITIONS</title><date>2018-02-01</date><risdate>2018</risdate><abstract>Compositions involving a modified egg yolk extract for use as an effective anti-cancer agent are described. The modified egg yolk extract involves specific fractions of phosphatidylcholines and sphingomyelins modified and produced from a chemical synthesis applied to the extract that produce a beneficial effect on the inhibition of cancerous cell growth. Methods of administering these compositions are also described.
L'invention concerne des compositions comprenant un extrait de jaune d'oeuf modifié destiné à être utilisé en tant qu'agent anticancéreux efficace. L'extrait de jaune d'oeuf modifié comprend des fractions spécifiques de phosphatidylcholines et de sphingomyélines modifiées et produites à partir d'une synthèse chimique appliquée à l'extrait qui produisent un effet bénéfique sur l'inhibition de la croissance des cellules cancéreuses. L'invention concerne également des méthodes d'administration de ces compositions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2018005735A9 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | PHOSPHOLIPID COMPOSITIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A52%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MIKNIS,%20Gregory,%20F&rft.date=2018-02-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2018005735A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |